217 related articles for article (PubMed ID: 3320743)
1. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD.
Buchegger F; Schreyer M; Carrel S; Mach JP
Int J Cancer; 1984 May; 33(5):643-9. PubMed ID: 6724739
[TBL] [Abstract][Full Text] [Related]
3. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
4. Interconversion between two electrophoretic forms of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA).
Krop-Watorek A; Sedlaczek P; Lisowska E
Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):703-14. PubMed ID: 2487380
[TBL] [Abstract][Full Text] [Related]
5. Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns.
Grunert F; AbuHarfeil N; Schwarz K; von Kleist S
Int J Cancer; 1985 Sep; 36(3):357-62. PubMed ID: 3839768
[TBL] [Abstract][Full Text] [Related]
6. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants.
Daniel S; Nagel G; Johnson JP; Lobo FM; Hirn M; Jantscheff P; Kuroki M; von Kleist S; Grunert F
Int J Cancer; 1993 Sep; 55(2):303-10. PubMed ID: 7690348
[TBL] [Abstract][Full Text] [Related]
7. Production kinetics and immunochemical properties of carcinoembryonic antigen and nonspecific cross-reacting antigen synthesized by various human tumor cell lines.
Ichiki S; Kuroki M; Kuroki M; Koga Y; Matsuoka Y
Jpn J Cancer Res; 1986 May; 77(5):462-72. PubMed ID: 2426231
[TBL] [Abstract][Full Text] [Related]
8. The molecular heterogeneity of nonspecific cross-reacting antigen synthesized by tumor cells and granulocytes.
Kuroki M; Kuroki M; Moore GE; Ichiki S; Matsuoka Y
Jpn J Cancer Res; 1988 Jan; 79(1):82-90. PubMed ID: 3128509
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of nonspecific cross-reacting antigens in human granulocytes.
Kuroki M; Arakawa F; Matsuo Y; Oikawa S; Misumi Y; Nakazato H; Matsuoka Y
J Biol Chem; 1991 Jun; 266(18):11810-7. PubMed ID: 2050678
[TBL] [Abstract][Full Text] [Related]
10. CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies.
Verstijnen CP; Arends JW; Moerkerk PT; Warnaar S; Hilgers J; Bosman FT
Anticancer Res; 1986; 6(1):97-104. PubMed ID: 2420267
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a species of non-specific cross-reacting antigen (NCA) expressed by human monocytic cell lines: structure and expression during cell differentiation.
Kuroki M; Yamanaka T; Matsuo Y; Ohtani T; Matsuo Y; Minowada J; Misumi Y; Oikawa S; Nakazato H; Matsuoka Y
Int J Cancer; 1994 Mar; 56(6):886-91. PubMed ID: 8119777
[TBL] [Abstract][Full Text] [Related]
12. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
Frénoy N; Schauffler J; Cahour A; Burtin P
Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
[TBL] [Abstract][Full Text] [Related]
13. Non-specific crossreacting antigen (NCA) does not contain methionine.
Abuharfeil N; Grunert F; von Kleist S
Tumour Biol; 1984; 5(6):339-50. PubMed ID: 6549526
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
[TBL] [Abstract][Full Text] [Related]
15. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
Burtin P
C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
[TBL] [Abstract][Full Text] [Related]
16. Three different NCA species, CGM6/CD67, NCA-95, and NCA-90, are comprised in the major 90 to 100-kDa band of granulocyte NCA detectable upon SDS-polyacrylamide gel electrophoresis.
Kuroki M; Matsuo Y; Kinugasa T; Matsuoka Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):501-6. PubMed ID: 1370882
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
18. The subunit structure of non-specific cross-reacting antigen (NCA).
Krop-Watorek A; Sedlaczek P; Lisowska E
Mol Immunol; 1983 Jul; 20(7):777-85. PubMed ID: 6412074
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of monoclonal antibodies against carcinoembryonic antigen (CEA).
Jantscheff P; Böttger V; Price M; Micheel B; Kaiser G; Zotter S; Kotzsch M; Grossmann H; Karsten U
Biomed Biochim Acta; 1991; 50(12):1261-7. PubMed ID: 1824544
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
Laferté S; Krantz MJ
Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
